Management of anxiety in the diagnosis of breast cancer Breast cancer review is the most common cancer in women. In 2008, more than 1 million women received diagnostic evaluation of suspicious breast cancer. Approximately 182,500 women of more than 1 million people evaluated also received a positive diagnosis (Montgomery, 2010). Risk factors associated with breast cancer include sex, age, family history, previous breast cancer, previous biopsy, race and ethnicity, breast density, and long-term monthly history with long-term hormone stimulation.
Breast mammography has become a standard diagnostic breast screening tool in women's health care that helps the early detection and intervention of breast cancer. Several doctors have reported that the mortality rate of breast cancer decreased by 30% as a result of periodic mammography examinations. For these statistics, it is recommended that women receive mammography every year since the age of 40. However, the advantages of conventional mammography are topics that are controversial in the medical community.
Evaluation of pros and cons of periodic mammography screening is the main theme of discussion and discussion in the medical community. Breast cancer screening test clearly helped reduce breast cancer mortality in the US from 33 deaths per 100 thousand in 1985 to 20.5 deaths of 100 thousand people in 2014. Nonetheless, annual or semi-annual mammography of women over 40 years of age means radiation exposure that may affect cancer risk. This is a dog that follows the tail. Furthermore, the diagnostic performance of mammogram interpretation is not high, the root cause of the dilemma is obvious. Perhaps the time has come to reconsider how doctors interpret mammography, but this is not to be considered when Becker and his colleagues try to apply cognitive computing to radiologic medicine There is no doubt.
In the breast cancer diagnostic test, we tried a new way to distinguish subtypes of various cancers, predict the outcome of specific cancers, and predict whether cancer will respond to a specific treatment. As with screening assays, diagnostic tests can investigate new medical imaging methods or biomarkers. Examination of quality of life (also called support care trial) is seeking ways to improve the comfort and quality of life for cancer patients and survivors. These tests may seek better ways to prevent or control nausea, fatigue, depression, pain, or other problems caused by cancer or its treatment. They can also test communication and educational methods to people about breast and breast health.